Robert E. Dudley
Officer, Director at Clarus Therapeutics Holdings, Inc. (CRXT)
Robert E. Dudley has filed 3 insider reports with the SEC since September 2021, as officer and director at Clarus Therapeutics Holdings, Inc. (CRXT) and officer and director at Clarus Therapeutics Holdings, Inc. (BLUWU). The latest filing, on December 15, 2021, reports grant or award at Clarus Therapeutics Holdings, Inc. (CRXT).
- Filings
- 3
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Robert E. Dudley is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Officer, Director | 139,566 | Dec 15, 2021 | |||||
| Officer, Directorsince September 2021 | 4,566 | $10.42 | Sep 14, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Dec 12, 2021CRXTSEC Form 4: Dudley Robert E. was granted 135,000 shares, increasing direct ownership by 2,957% to 139,566 unitsForm 4Grant or award
- Sep 9, 2021BLUWUSEC Form 4: Dudley Robert E. was granted 4,566 units of Common StockForm 4Grant or award
- Sep 9, 2021BLUWURobert E. Dudley became an insiderForm 3New insider
Also sits on boards with
Officers and directors who share two or more companies with Robert E. Dudley.
- Joseph Hernandez2 shared: BLUWU, CRXT
- Mark A Prygocki Sr2 shared: CRXT, BLUWU
- John Kenneth Amory2 shared: CRXT, BLUWU
- Elizabeth Cermak2 shared: CRXT, BLUWU
- Frank Jaeger2 shared: CRXT, BLUWU
- Richard D Peterson2 shared: CRXT, BLUWU
- Steven A. Bourne2 shared: CRXT, BLUWU
Compare Robert E. Dudley with
- Robert E. Dudley vs Joseph Hernandez2 shared
- Robert E. Dudley vs Mark A Prygocki Sr2 shared
- Robert E. Dudley vs John Kenneth Amory2 shared
- Robert E. Dudley vs Elizabeth Cermak2 shared
- Robert E. Dudley vs Frank Jaeger2 shared
- Robert E. Dudley vs Richard D Peterson2 shared
Other insiders at the same companies
- Mark AngeloBLUWU
- Scott GlabeBLUWU
- Mark S HiltweinBLUWU
- Devin G. NunesBLUWU
- Troy RilloBLUWU
- Kevin McGurnBLUWU
- Blue Water Acquisition III LLCBLUWU
- Laurent Didier HermouetBLUWU
- Martha F. RossBLUWU
- Trevor Leonard HawkinsBLUWU
- Timothy Neal CoulsonBLUWU
- Ishdeep DugalBLUWU
Questions about Robert E. Dudley
- What is Robert E. Dudley's role at Clarus Therapeutics Holdings, Inc.?
- Robert E. Dudley reports to the SEC as officer and director at Clarus Therapeutics Holdings, Inc. (CRXT), according to the latest filing on December 15, 2021. Robert E. Dudley has also filed as officer and director at Clarus Therapeutics Holdings, Inc. (BLUWU).
- How many shares does Robert E. Dudley own?
- After the latest filing that states it, Robert E. Dudley directly owned 139,566 shares of Clarus Therapeutics Holdings, Inc. (CRXT) and 4,566 shares of Clarus Therapeutics Holdings, Inc. (BLUWU). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Robert E. Dudley bought or sold stock recently?
- No open-market purchases or sales by Robert E. Dudley are on file. The filings report grant or award.
- How do I get alerts when Robert E. Dudley files?
- Follow Robert E. Dudley on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Robert E. Dudley (SEC CIK 0001510208). Totals count each trade once, skipping amendments whose original is on file, from Sep 14, 2021 on. View on SEC EDGAR · Get this as JSON